Kripa Nand
Research areas: Immunology and Microbiology · Immunology · Immunotherapy and Immune Responses · Reproductive Health and Contraception · Cervical Cancer and HPV Research
0009-0002-9201-4719
About
I am a biotechnology researcher with a passion for understanding biology and turning scientific ideas into meaningful solutions for human health. My experience spans cancer immunology, vaccine development, recombinant proteins, VLPs, mammalian cell biology, cell engineering, biomaterials, and translational research.
What drives me is the opportunity to ask meaningful biological questions, solve challenging problems, and translate discoveries into practical technologies and therapies. I also enjoy mentoring students and collaborating across disciplines, because I believe good science grows through curiosity, teamwork, and continuous learning.
My research is now moving toward cell-surface engineering, extracellular vesicles, biomaterials, and cancer biology, with a growing interest in how we can engineer cells and their microenvironment to control biological function.
Looking ahead, I aim to build an independent research program at the intersection of cell biology, biomaterials, cancer research, and therapeutic development, with the goal of developing innovative approaches that can ultimately make a meaningful impact on human health.
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (27)
- The assembly pathway for human papillomavirus L1 capsid protein is encoded in electrostatic interactions Save
- Electrostatic potential is the dominant force in antigenic selection of naïve T-cells and B-cells for activation and maturation Save
- Overexpression and characterization of recombinant hCGβ-LTB vaccine in fed-batch culture of yeast Pichia pastoris Save
- Bacterial production of recombinant contraceptive vaccine antigen from CatSper displayed on a human papilloma virus-like particle Save
- The two sides of the covid-19 pandemic Save
- Yeast-based virus-like particles as an emerging platform for vaccine development and delivery Save
- Expression and Characterization of in vitro Aggregates and Inclusion Bodies of $α$-synuclein in E. coli Save
- A unique vaccine for birth control and treatment of advanced stage cancers secreting ectopically human chorionic gonadotropin Save
- HPV VLPs as scaffolds for vaccine design Save
- The Recombinant Vaccine against Human Chorionic Gonadotropin goes on Combined Immunogenicity, Safety and Efficacy Clinical Trials Save
- The Recombinant Vaccine against Human Chorionic Gonadotropin goes on Combined Immunogenicity, Safety and Efficacy Clinical Trials Save
- Current status of a unique vaccine preventing pregnancy Save
- Effectiveness of a monoclonal antibody against human chorionic gonadotropin (hCG) to prevent reproductive and metabolic dysfunctions in transgenic female mice Save
- A unique genetically engineered vaccine against human chorionic gonadotropin that prevents pregnancy without impairment of ovulation, hormonal profiles, and menstrual regularity Save
- Archives in Microbiology & Immunology Save
- Human Chorionic Gonadotropin is an Ideal Target for Immuno-Contraception, Development of a Potential Birth Control Vaccine with Additional use for Immunotherapy of Advanced Stage Cancers Save
- Making of vaccines against human chorionic gonadotrophin for control of fertility of women without impairment of ovulation and menstrual regularity Save
- Advances in development of a contraceptive vaccine against human chorionic gonadotropin Save
- Development of a recombinant hCG-specific single chain immunotoxin cytotoxic to hCG expressing cancer cells Save
- Priming with DNA Enhances Considerably the Immunogenicity of hCG b-LTB Vaccine Save